|
NNT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.24810000001752E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.85849999999799E-05 |
| Normal-vs-Stage2 |
2.534200E-01 |
| Normal-vs-Stage3 |
2.717400E-03 |
| Normal-vs-Stage4 |
4.45109999969162E-07 |
| Stage1-vs-Stage2 |
4.020400E-01 |
| Stage1-vs-Stage3 |
3.715400E-01 |
| Stage1-vs-Stage4 |
1.616470E-02 |
| Stage2-vs-Stage3 |
2.363000E-01 |
| Stage2-vs-Stage4 |
3.502100E-02 |
| Stage3-vs-Stage4 |
2.891600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.76379999997189E-06 |
| Normal-vs-AfricanAmerican |
1.904490E-03 |
| Normal-vs-Asian |
1.276010E-01 |
| Caucasian-vs-AfricanAmerican |
6.865200E-01 |
| Caucasian-vs-Asian |
7.426200E-01 |
| AfricanAmerican-vs-Asian |
6.218600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.08539999987833E-07 |
| Normal-vs-Female |
4.902400E-02 |
| Male-vs-Female |
1.030790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.959300E-03 |
| Normal-vs-Extreme_Weight |
1.96587999999887E-05 |
| Normal-vs-Obese |
2.31609999999938E-05 |
| Normal-vs-Extreme_Obese |
4.552200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.509200E-01 |
| Normal_Weight-vs-Obese |
8.658800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.438000E-01 |
| Extreme_Weight-vs-Obese |
9.783000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.436000E-01 |
| Obese-vs-Extreme_Obese |
3.133200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.659660E-03 |
| Normal-vs-Age(41-60Yrs) |
4.34310000000382E-05 |
| Normal-vs-Age(61-80Yrs) |
8.18320000000039E-05 |
| Normal-vs-Age(81-100Yrs) |
4.174400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.116800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.203400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.611200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.991000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.948200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.692000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.0653000004357E-07 |
| Normal-VS-Type2 PRCC |
6.057900E-02 |
| Normal-VS-KIRP CIMP |
5.41829914268988E-11 |
| Normal-VS-Unclassified PRCC |
1.894420E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.219700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.24920000002626E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.623900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.33570000404993E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
8.656200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.60640000004919E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.582030E-04 |
| Normal-vs-N1 |
1.45640000004388E-06 |
| Normal-vs-N2 |
4.25329999997892E-06 |
| N0-vs-N1 |
9.814200E-02 |
| N0-vs-N2 |
1.617430E-01 |
| N1-vs-N2 |
4.511400E-01 |
|
|
